key: cord-0864266-bc08ckx8
authors: Aljohani, Fahad Dakilallah; Khattab, Amin; Elbadawy, Hossein M.; Alhaddad, Aisha; Alahmadey, Ziab; Alahmadi, Yaser; Eltahir, Heba M.; Matar, Heba M. H.; Wanas, Hanaa
title: Prognostic factors for predicting severity and mortality in hospitalized COVID‐19 patients
date: 2022-01-25
journal: J Clin Lab Anal
DOI: 10.1002/jcla.24216
sha: b0058ff3f2d26c8a94f55c6ab6fa0efddbeeecad
doc_id: 864266
cord_uid: bc08ckx8

BACKGROUND: Coronavirus disease 2019, COVID‐19, has reached all the corners of the world and was declared by the WHO as a global pandemic and public health emergency of international concern on the January 31, 2020. Allocating quick and specific biomarkers to predict the disease severity upon admission to hospital became a crucial need. This study, therefore, aimed at exploring the relationship between laboratory results in COVID‐19 patients admitted to hospital and the final outcome in these patients. METHODS: Retrospective analysis was performed on the medical records of 310 COVID‐19‐positive patients admitted to Uhod Hospital, the referral hospital in the area of Madinah, Kingdom of Saudi Arabia, between the April 13 and the July 29, 2020. The association of laboratory results with the survival/mortality outcomes was studied. RESULTS: It was demonstrated that lymphopenia, prolonged aPTT, high INR, high D. dimer and high CK are valuable prognostic predictors of the severity of the disease at early stages that can determine the outcome. Based on the results of the multiple logistic regression, the variables that are associated with death outcome are aPTT, HR, RR, ALT and CK level CONCLUSION: It is proposed to perform these tests on admission to hospital for moderate to severe COVID‐19 patients to improve the management of those cases and reduce mortality.

Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become an emergency concern due to its invasive and ambiguous nature. 1, 2 Since the beginning of the pandemic in December 2019, it has infected 61.8 million cases and caused 1.4 million deaths as per the December 1, 2020, as reported by the World Health Organization. 3, 4 COVID-19 patients mostly present with fever, dyspnea and dry cough. However, in 8-15% of cases, depending on geographical and individual variations, it can lead to a severe illness requiring specialized management at intensive care units. 1 A number of COVID-19 patients may also develop acute respiratory distress syndrome which can occasionally progress to multiorgan failure and death. 5 The high infectivity nature of the SARS-CoV-2 virus and the inability to predict the severity of the infection at early stages of the disease led to increasing mortality rates. The hospitalization rate for COVID-19 ranges between 20.7 and 31.4% while a mortality rate of 3.4% was found to be higher than seasonal flu official rates, as reported by the WHO Director-General's opening remarks at the media briefing on COVID-19 on the March 11, 2020. Quick identification of patients who may, potentially, develop severe illness and require intensive care or mechanical ventilation is important for decreasing mortality rates of COVID-19. This will eventually improve the efficient utilization of health care resources which are already under strain worldwide due to the successive waves of this ongoing pandemic. 6 Laboratory findings and chronic comorbidities are important to determine the diagnosis and prognosis of COVID-19. 7, 8 The initial tests for COVID-19 patients are complete blood count (CBC), inflammatory and coagulation cascade parameters and other biochemical factors to determine the functionality of vital organs. 9 Vital signs at presentation represent an important indication of severity, used to decide on the therapeutic plan and to monitor patients who are at the risk of developing severe respiratory symptoms. 10 Analyzing laboratory findings of COVID-19 patients on admission to hospital can be used as an initial indicator of severity. 11 Investigation of these parameters can give an insight into the severity of disease and its possible outcomes. Therefore, laboratory findings and vital signs, together, can play a fundamental role in the diagnosis and prognosis of COVID-19 patients. 12 In the current study, clinical and laboratory data of 310 hospitalized COVID-19 cases were analyzed to assess the importance of laboratory findings and vital signs in predicting the final outcome of COVID-19 patients upon admission to hospital and to find possible biomarkers which can provide clinically important prognostic indicators of the progression of the disease at early stages.

This study included COVID-19 patients with positive polymerase chain reaction (PCR) (310) admitted to Uhod Hospital, the referral hospital in the area of Madinah, western region of the Kingdom of Saudi Arabia between April 13 and July 29, 2020. Data were extracted retrospectively from the hospital information system by two groups and then cross-checked. Patients less than 18 years old were not included from the study. Data included sex, age, previous comorbidities, vital signs and laboratory results on admission including respiration rate (RR), heart rate (HR), mean arterial blood pres- 

Descriptive statistics for the variables were presented in the form of mean, standard deviation, median, quartiles. Multiple logistic regression was used to study the association between the death outcome and lab test results and vital signs while controlling for other variables. Variables were entered in the model in their numeric forms and were selected manually if the P-value for the simple logistic regression is <0.2. IBM SPSS version 26 for Windows software was used for the analysis. A P-value of < 0.05 was considered significant. In the multivariate analysis, the backward stepwise method was used to remove variables that are not significantly predicting mortality.

This study included 310 COVID-19-positive patients admitted to hospital with respiratory symptoms ranging from mild, moderate, severe to critical ( Table 1 ). The study did not include patients with no respiratory symptoms requiring only home isolation. The demographic data are presented in Table 

Patients with SpO2 of 93% or above were maintained at room air, while patients with SpO2 below 93% were on external oxygen support or invasive ventilation according to the severity of each case.

Vital signs were taken on day 1 after admission to hospital and assigning oxygen support or mechanical ventilation according to need.

The majority of patients maintained a normal heart rate (HR), respiratory rate (RR), mean arterial blood pressure (BP) and peripheral oxygen saturation (SpO 2 ) as shown in Table 2 . Although fever was the presenting symptom in almost all patients, all temperatures were normal because patients were already on antipyretic medication shortly after admission.

All patients received a treatment regimen including anticoagulant, antiviral and antibiotics as per the MOH protocol at that time.

Additional medications were given for chronic diseases including antihyperlipidemic drugs (statins), antihypertensives and antidiabetic drugs. Antifungal drugs, corticosteroids, mucolytics, bronchodilators, antitussive drugs, multivitamins and other drugs were given according to the need of each patient. During the management plan, 54.4% of patients required supplemental oxygen either through nasal cannula (25.1%); Face mask (15.2%); non-rebreather mask (4.2%) or invasive ventilation (9.9%) ( Table 2 ).

Multiple logistic regression was used to study the association between the death outcome and vital signs at presentation while controlling for other variables. The variables that showed significant association (P-value < 0.05) are the heart rate (HR), respiratory rate (RR) and the peripheral O2 saturation (SpO2). Patients in the group who died showed higher HR, higher RR and lower SpO2 compared to those who survived with P-value of (0.001), (< 0.001) & (<0.001), respectively (Table 3 ).

Multiple logistic regression was used to study the association between the death outcome and lab test results. The variables that showed statistically significant association (P-value < 0.05) are the lymphocytes count, CRP, aPTT, INR, D. dimer, ALT and CK. However, the other laboratory results abnormalities did not show statistically significant association with the outcome (Table 3 ).

As shown in Table 3 , patients who died had lower hematocrit (Ht), RBCs, hemoglobin (Hb), PLTs, WBCs, neutrophils and lymphocytic count as compared to those who recovered. Among those parameters, only the low lymphocytic count was significantly correlated with the death outcome with P-value less than (0.001).

A number of inflammatory and blood coagulation parameters were investigated, including CRP, serum ferritin, aPTT, INR and D-dimer. Elevated ferritin showed no significant indication (Table 3) .

A significant correlation was found between ALT, CK and the final outcome in COVID-19 patients. Patients who did not recover had Bold values are statistically significant P < 0.05.

higher CK as compared to those who recovered with P-value of (0.009). However, Patients who did not recover had lower ALT level as compared to those who recovered with P-value of (0.001). On the other hand, serum creatinine, serum albumin, AST, serum bilirubin and LDH did not significant association with the outcome (Table 3) .

In this model, the backward stepwise method was used to remove 

The In this study, it was found that low lymphocyte count was associated with death as a final outcome. These results are in agreement with previous studies where lymphopenia was shown to be more frequently encountered in severe cases. [14] [15] [16] Remarkably, lymphopenia was a prevailing feature in SARS infections. 17 the results from the current study did not find a prognostic value for leukocytosis, neutrophilia or thrombocytopenia as presented in some previous series. 14, 22 The prognostic significance of laboratory tests was not limited coagulopathy. 23 The exact mechanism of this phenomenon is not clear yet, however, endothelial damage in COVID-19 infection was shown to trigger platelet aggregation and consumption with subsequent microvascular thrombosis. 22, 24, 25 Coagulopathy, defined as spontaneous prolongation of prothrombin time (PT) > 3s or an activated partial thromboplastin time (aPTT) > 5s, was reported as an independent predictor of thrombotic complications. 23 In our results, patients in the non-survivors group demonstrated prolonged aPTT, a finding which comes in agreement with a previous retrospective analysis. 26 Additionally, elevated D-dimer and prolonged INR showed significant association with the mortality outcome as shown in other previous studies. 26 Among the biochemical parameters analyzed in this study, elevation of CK showed positive association with the severity of the disease and death. Creatine kinase (CK) is an essential enzyme to intracellular energy transport and muscle contraction. 27-29 CK is mainly found in cardiac and skeletal muscles, brain, lungs and GIT and is released in different pathological conditions of these tissues. 30 

Declared none.

None of the authors has any potential financial conflict of interest related to this manuscript.

Ethical approval was obtained from the institutional review board for research ethics, general directorate of health affairs in Madinah (H-03-M-084).

Data supporting the findings of this study are available from the corresponding author on request.

Hanaa Wanas https://orcid.org/0000-0002-7109-939X

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating personto-person transmission: a study of a family cluster

Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). World Health Organization W

Severe outcomes among patients with coronavirus disease 2019 (COVID-19)-United States

COVID-19 and multi-organ response

Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis

Clinical features and potential risk factors for discerning the critical cases and predicting the outcome of patients with COVID-19

Predictive criteria of severe cases in COVID-19 patients of early stage: A retrospective observational study

Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury

Analysis of clinical features and outcomes of 161 patients with severe and critical COVID-19: a multicenter descriptive study

Patient characteristics and admitting vital signs associated with coronavirus disease 2019 (COVID-19)-related mortality among patients admitted with noncritical illness

Clinical characteristics and factors affecting the duration of positive nucleic acid test for patients of COVID-19 in XinYu

Delta-9-THC exposure during zebra finch sensorimotor vocal learning increases cocaine reinforcement in adulthood

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan. China

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan. China

Hematological findings in SARS patients and possible mechanisms

Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients

Functional exhaustion of antiviral lymphocytes in COVID-19 patients

COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?

Insight into 2019 novel coronavirus-an updated interim review and lessons from SARS-CoV and MERS-CoV

Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis

Incidence of thrombotic complications in critically ill ICU patients with COVID-19

Thrombocytopenia in patients with severe acute respiratory syndrome

Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past

Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

Creatine kinase of rat heart mitochondria coupling of creatine phosphorylation to electron transport

Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit'for cellular energy homeostasis

The Interaction of 8-Anilino-1-naphthalenesulfon ate with Creatine Kinase evidence for cooperativity of nucleotide binding

Demonstration of creatine phosphokinase in human lung tissue

Incidence of acute kidney injury in COVID-19 infection: a systematic review and meta-analysis

Meta-analysis of relation of creatine kinase-MB to risk of mortality in coronavirus disease 2019 patients

Lactate dehydrogenase level as a COVID-19 severity marker

The correlation between viral clearance and biochemical outcomes of 94 COVID-19 infected discharged patients

Laboratory findings in COVID-19 diagnosis and prognosis

Prognostic factors for predicting severity and mortality in hospitalized COVID-19 patients